DMS Group: FDA Clearance and U.S. Launch of !M1 System

On May 12, 2025, Diagnostic Medical Systems (DMS) announced FDA clearance for their !M1 mobile radiology solution, enabling its commercialization in the U.S. market. This follows a strategic agreement with Medlink Imaging, part of Korean company Vieworks, for U.S. distribution.

Medlink Imaging will immediately begin deliveries, utilizing their nationwide network and integrating Vieworks detectors with the !M1. DMS Group CEO, Samuel Sancerni, sees this as a strategic milestone, emphasizing DMS's international growth ambitions, particularly in the dynamic U.S. mobile radiology market.

The U.S. market represents a significant opportunity, with over 1,200 mobile radiology units sold annually. The !M1, developed by Solutions for Tomorrow, is praised for its mobility, compactness, clinical performance, and adaptability to complex environments.